Korro Bio, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Korro Bio, Inc. (KRRO) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $1.47 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2019-11-18
- 2019-09-30: Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month $1.47M.
- 2018-09-30: Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month $345.00K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month |
|---|---|
| 2019-09-30 | $1.47M 10-Q · filed 2019-11-18 |
| 2018-09-30 | $345.00K 10-Q · filed 2019-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |